203 related articles for article (PubMed ID: 22806900)
1. Paracrine role for TGF-β-induced CTGF and VEGF in mesangial matrix expansion in progressive glomerular disease.
Lee HS
Histol Histopathol; 2012 Sep; 27(9):1131-41. PubMed ID: 22806900
[TBL] [Abstract][Full Text] [Related]
2. Differential role of mesangial cells and podocytes in TGF-beta-induced mesangial matrix synthesis in chronic glomerular disease.
Lee HS; Song CY
Histol Histopathol; 2009 Jul; 24(7):901-8. PubMed ID: 19475536
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic role of TGF-β in the progression of podocyte diseases.
Lee HS
Histol Histopathol; 2011 Jan; 26(1):107-16. PubMed ID: 21117032
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
Lee HS
Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
[TBL] [Abstract][Full Text] [Related]
5. CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells.
Weston BS; Wahab NA; Mason RM
J Am Soc Nephrol; 2003 Mar; 14(3):601-10. PubMed ID: 12595495
[TBL] [Abstract][Full Text] [Related]
6. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
Lee HS; Song CY
Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
[TBL] [Abstract][Full Text] [Related]
7. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
9. Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
Umezono T; Toyoda M; Kato M; Miyauchi M; Kimura M; Maruyama M; Honma M; Yagame M; Suzuki D
J Nephrol; 2006; 19(6):751-7. PubMed ID: 17173248
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of connective tissue growth factor and of TGF-beta isoforms during glomerular injury recapitulate glomerulogenesis.
Ito Y; Goldschmeding R; Kasuga H; Claessen N; Nakayama M; Yuzawa Y; Sawai A; Matsuo S; Weening JJ; Aten J
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F545-58. PubMed ID: 20576680
[TBL] [Abstract][Full Text] [Related]
11. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells.
Murphy M; Godson C; Cannon S; Kato S; Mackenzie HS; Martin F; Brady HR
J Biol Chem; 1999 Feb; 274(9):5830-4. PubMed ID: 10026205
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis.
Riser BL; Cortes P
Ren Fail; 2001; 23(3-4):459-70. PubMed ID: 11499561
[TBL] [Abstract][Full Text] [Related]
13. Isoliquiritigenin entails blockade of TGF-beta1-SMAD signaling for retarding high glucose-induced mesangial matrix accumulation.
Li J; Kang SW; Kim JL; Sung HY; Kwun IS; Kang YH
J Agric Food Chem; 2010 Mar; 58(5):3205-12. PubMed ID: 20146476
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory smads and tgf-Beta signaling in glomerular cells.
Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
[TBL] [Abstract][Full Text] [Related]
15. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
[TBL] [Abstract][Full Text] [Related]
16. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
Yokoi H; Mukoyama M; Mori K; Kasahara M; Suganami T; Sawai K; Yoshioka T; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
Kidney Int; 2008 Feb; 73(4):446-55. PubMed ID: 18075496
[TBL] [Abstract][Full Text] [Related]
19. Evidence for low-density lipoprotein-induced expression of connective tissue growth factor in mesangial cells.
Sohn M; Tan Y; Klein RL; Jaffa AA
Kidney Int; 2005 Apr; 67(4):1286-96. PubMed ID: 15780081
[TBL] [Abstract][Full Text] [Related]
20. Purple corn anthocyanins dampened high-glucose-induced mesangial fibrosis and inflammation: possible renoprotective role in diabetic nephropathy.
Li J; Lim SS; Lee JY; Kim JK; Kang SW; Kim JL; Kang YH
J Nutr Biochem; 2012 Apr; 23(4):320-31. PubMed ID: 21543205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
